Concepedia

Lisa Geiselhart

LG

5

Publications

454

Citations

5

H-Index

1996

Active since

Affiliations

Science Applications International Corporation (United States)(Current)

National Cancer Institute

Frederick National Laboratory for Cancer Research

Albany Medical Center Hospital

Center for Cancer Research

Lisa Geiselhart is an author at Science Applications International Corporation (United States) specializing in immunology, immunotherapy, and medicine.

Top concepts

Publications per year

1996–2001

5

Publications

5

IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation

Lisa Geiselhart, Courtney A. Humphries, T A Gregorio et al. · The Journal of Immunology · 2001 · 139 citations

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart et al. · Journal of Clinical Investigation · 2001 · 126 citations · Full text

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart et al. · Journal of Clinical Investigation · 2001 · 109 citations

, , +16

Inhibition of Human T Lymphoblast Proliferation by Hydroquinone

Qing Li, Lisa Geiselhart, James N. Mittler et al. · Toxicology and Applied Pharmacology · 1996 · 52 citations

, , +3

The Cigarette Tar Componentp-Benzoquinone Blocks T-Lymphocyte Activation by Inhibiting Interleukin-2 Production, but Not CD25, ICAM-1, or LFA-1 Expression

Lisa Geiselhart, Todd Christian, Fred L. Minnear et al. · Toxicology and Applied Pharmacology · 1997 · 28 citations

, , +12

Rows per page

1–5 of 5